Past few days, antipyretics for children of nimesulide However, many pharmacies have panic the face of this storm, the shelves are still full spectrum
Hong Chi Pharmaceutical behind the finger at Johnson & Johnson
antipyretics children in the domestic market, the main component of nimesulide as a ibuprofen as the main ingredient in Johnson & Johnson, Pharmaceutical aspects of health, said Chi, compared with Merrill Lynch, Rui Zhiqing to price advantage,
Hongjiang Tour chairman, said in an interview, over the past decade, our country does not nimesulide adverse reactions related to communications, Rui Zhiqing listed nine years, is to produce satisfactory results. The mastermind behind the event, Johnson is likely to be multinationals.
the possibility of speculation to be traced back to November 26 last year, referred to as Subsequently, Johnson appeared on the official website disabled
present, Hong Chi Commerce and Industry Bureau of Hainan has been submitted to malicious competition against opponents and other bad behavior.
to prove his innocence, Hong Chi has been with the FDA to communicate and Merrill Lynch is willing to do the Ruizhi Qing drug safety evaluation comparison, for scientific evaluation.
Johnson still did not
Food and Drug Administration experts: the cause of death from improper use rather than the drugs themselves
onto the cusp of p>
State Food and Drug Administration recently said that monitoring of adverse reactions from the current point of view, does not appear abnormal, the current state of nimesulide is still the Food and Drug Administration approval to allow antipyretics for children . In addition, the National Adverse Drug Reaction Centre is organizing its security experts for further argument. Guangdong Food and Drug Administration also said the province were monitored between 9 to 133 cases of adverse reactions, but no cases of liver damage children.
It is understood that, in June 2008, the SFDA had to modify the instructions of nimesulide on the indications, usage, dosage, contraindications, precautions and so have been revised, more clearly to remind the medicine only for children over 1 year old, a dose of 5mg/kg body weight / day in 2-3 divided doses, maximum dose of no more than 100mg, 1 day 2 times daily for not more than 3 days.
rational use of Ministry of Health expert Professor Sun Zhongshi monitoring system that a few years ago, the international medical community and pharmaceutical worlds have for the safety of Nimesulide controversy, but in recent years, home and abroad have Some of the clinical research literature, including a 40 million large sample of clinical studies have shown that nimesulide and other non-steroidal anti-inflammatory drugs, such as ibuprofen, acetaminophen and other similar drugs compared to the town of antipyretic pain results have been very, very bad reaction.
Professor Sun that the National Adverse Drug Reaction Monitoring Centre of the vast majority of collected reports of adverse drug reactions, drug quality is not the problem, but with the improper use of drugs. Several children's deaths, child deaths and did not find
incident leading to Hong Chi shares plummet
positive interpretation of experts to dispel all doubts not, negative news on the matter follow.
learned from the European Medicines Agency, Department of Health, Hong Kong, China and other foreign authorities learned that nimesulide not only not recommended for use by children, their legal offshore antipyretics, the EU also prohibited fever, flu patients.
affect the situation as a whole, overnight, and was sought after by many institutions become institutions Kang Chi Pharmaceutical Antipyretics day of the accident, Kang Chi Pharmaceutical shares to 64.5 yuan from the morning sharply lower open, share prices will be down quickly, and repeatedly hit daily limit. Strongly suppress short of funds under the Hong Chi Pharmaceutical plunged 8.49% to close at the end,
fact, this is not the first time Hong Chi Pharmaceutical contrarian heavy volume tumbled. February 14 this year, a media report Kang Chi Pharmaceutical Products Nimesulide caused 20 cases of liver damage, its main business or crises, the company despite the emergency suspension, and at noon to be clarified, but the stock still plummeted after resumption of trading , single-day drop to 5.02%, turnover reached 209 million, compared to the previous average daily turnover of about 30 million yuan a huge increase.
the target of criticism in the media, the Hong Chi Pharmaceutical next two trading days the share price remained low, the minimum has dropped to 64.8 yuan, while 17 February oversold bounce, but the February 18 Japan once again plunged 3.7%. According to report statistics, in February 14 to 18 weeks time, the GEM that rose to 2.7%, and 138 stocks in the sector to achieve higher, while Hong Chi Pharmaceutical has plunged 8.17%.
information display according to the Shenzhen Stock Exchange publicly traded yesterday, five institutions to sell medicine in Hong seats in the top five in Chicago, amounted to 207 million total sold, accounting for stock trading day The total amount of 36.19%. Hong Chi Pharmaceutical day if the average price of 59.93 yuan to calculate the transaction, the five institutions to sell shares to 345.46 million shares actually! According to the Hong Chi Pharmaceutical three quarterly in 2010 showed that the circulation of shareholders holding more than 70 million shares, only five funds.
the main product appears in the pre-crisis, Hong Chi medicine has always been a and 17.1862 million yuan, institutions will rush to raise significantly, and in the May 28, 2010 and January 25 this year, two seats in the transaction list, there were large-scale institutional buying Hong Chi Pharmaceutical seats. In addition, shareholders in its circulation list of agencies can be found in favor of Hong Chi Pharmaceutical a plus. Statistics, as of September 30, 2010, Hong Chi Pharmaceutical top 10 tradable shareholders are fund companies, of which 122 million shares held by the social security portfolio 603, the second largest shareholders of circulation for the stock, while the rich countries, Yinhua other fund companies also rank the list of top 10 tradable shareholders.
reporter intern Xionghan Ling Niu Siyuan
No comments:
Post a Comment